Atorvastatin Calcium
- Product NDC
- 0615-7769
- 11-digit product format
- 006157769
- Labeler code
- 0615
- Product ID
- 0615-7769_f2542d36-8358-4746-b9ae-9c193aa65d09
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Atorvastatin Calcium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NCS HealthCare of KY, Inc dba Vangard Labs
- Application
- ANDA091650
- Marketing category
- ANDA
- Marketing start
- 2012-07-17
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 10 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0615-7769-05 | 2021-03-05 | C162847 | 48780-1 | 9d75b9d1-2a03-f424-e053-dadaa90a57ce | e10ae715-81e6-4089-9fc3-fa2d10171ed6 |
| 0615-7769-30 | 2021-03-05 | C162847 | 48780-1 | 9d75b9d1-2a03-f424-e053-dadaa90a57ce | e10ae715-81e6-4089-9fc3-fa2d10171ed6 |
| 0615-7769-39 | 2021-03-05 | C162847 | 48780-1 | 9d75b9d1-2a03-f424-e053-dadaa90a57ce | e10ae715-81e6-4089-9fc3-fa2d10171ed6 |
| 0615-7769-05 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-2a03-f424-e053-dadaa90a57ce | e10ae715-81e6-4089-9fc3-fa2d10171ed6 |
| 0615-7769-30 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-2a03-f424-e053-dadaa90a57ce | e10ae715-81e6-4089-9fc3-fa2d10171ed6 |
| 0615-7769-39 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-2a03-f424-e053-dadaa90a57ce | e10ae715-81e6-4089-9fc3-fa2d10171ed6 |